Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Appointed director

CytomX Therapeutics, Inc. (CTMX) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
06/16/2023 4 Meyers James R (Director) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $1.57, valued at $39.3k
06/16/2023 4 Mohindru Mani (Director) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $1.57, valued at $39.3k
06/16/2023 4 Young Matthew P. (Director) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $1.57, valued at $39.3k
06/16/2023 4 Ashworth Alan (Director) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $1.57, valued at $39.3k
06/16/2023 4 Gilbert Halley E (Director) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $1.57, valued at $39.3k
06/16/2023 4 Jones Elaine V (Director) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $1.57, valued at $39.3k
05/23/2023 4 McCarthy Sean A. (CEO) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Exercised 16,535 options to buy @ $1.5749, valued at $26k
03/31/2023 4 Jones Elaine V (Director) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Bought 5,000 shares @ $1.55, valued at $7.8k
03/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/29/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
03/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/20/2023 4 ROWLAND LLOYD A (General Counsel) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Sold 2,037 shares @ $1.979, valued at $4k
03/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/06/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/06/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/06/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/06/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/12/2022 4 McCarthy Sean A. (CEO) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Granted 450,000 options to buy @ $1.59, valued at $715.5k
Granted 75,000 options to buy @ $0
08/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2022 4 Peterson Amy C. (EVP, Chief Development Officer) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Granted 20,000 shares @ $0
Sold 7,463 shares @ $1.422, valued at $10.6k
07/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2022 4 McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Granted 40,000 shares @ $0
Sold 14,911 shares @ $1.4222, valued at $21.2k
07/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2022 4 HANNAH ALISON L. (Chief Medical Officer) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Granted 15,000 shares @ $0
Sold 5,602 shares @ $1.4219, valued at $8k
07/21/2022 4 Campoy Carlos (CFO) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Granted 15,000 shares @ $0
Sold 3,949 shares @ $1.4224, valued at $5.6k
06/17/2022 4 Young Matthew P. (Director) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $1.72, valued at $43k
06/17/2022 4 Mohindru Mani (Director) has filed a Form 4 on CytomX Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $1.72, valued at $43k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy